comparemela.com

Latest Breaking News On - Prometheus biosciences - Page 1 : comparemela.com

Vaccines tsar sells biotech start-up to US pharma group Merck in £2 4bn deal

EyeBio chairman Dame Kate Bingham (pictured) led Britain s Covid vaccine task force in early 2020 and is the chairman of EyeBio.

Merck Reportedly Nearing $1 3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co (NYSE:MRK)

Merck & Co is reportedly on the verge of acquiring EyeBio, an eye-drug company, for a sum of $1.3 billion. This acquisition is expected to significantly expand Merck's presence in the rapidly growing eye-care market.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.